Human adult stem cell therapy (Neuronyx)

N/A

Report date: 2023/02/11 20:38:12

Base Information

Drug NameHuman adult stem cell therapy (Neuronyx)
Drug Alias NameNX-CP105
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsMyocardial InfarctionMyocardial IschemiaSpinal Cord Injuries +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGarnet Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGarnet Biotherapeutics Inc
Active IndicationsN/A
Inactive IndicationsMyocardial InfarctionMyocardial IschemiaSpinal Cord Injuries +[4] 

Other Information

ATC CodeN/A
Related LinksN/A